Pfizer
PFE
$25.39
Share price
-0.12%
Change (1 day)
-37.39%
Change (1 year)
Categories
Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.
Pfizer (PFE) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $137.21 B
According to Pfizer's latest financial reports the company's total liabilities are $137.21 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Pfizer - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $137.21 B | 35.47% |
| 2022-12-31 | $101.28 B | -2.62% |
| 2021-12-31 | $104.01 B | 14.61% |
| 2020-12-31 | $90.75 B | -12.86% |
| 2019-12-31 | $104.14 B | 8.87% |
| 2018-12-31 | $95.66 B | -4.47% |
| 2017-12-31 | $100.14 B | -10.41% |
| 2016-12-31 | $111.77 B | 9.17% |
| 2015-12-31 | $102.38 B | 6.71% |
| 2014-12-31 | $95.94 B | 0.48% |
| 2013-12-31 | $95.48 B | -8.3% |
| 2012-12-31 | $104.12 B | -1.2% |
| 2011-12-31 | $105.38 B | -1.28% |
| 2010-12-31 | $106.74 B | -12.86% |
| 2009-12-31 | $122.50 B | 129.37% |
| 2008-12-31 | $53.40 B | 6.51% |
| 2007-12-31 | $50.14 B | 13.67% |
| 2006-12-31 | $44.11 B | -13.85% |
| 2005-12-31 | $51.20 B | -6.56% |
| 2004-12-31 | $54.80 B | 6.62% |
| 2003-12-31 | $51.39 B | 94.65% |
| 2002-12-31 | $26.40 B | 26.59% |
| 2001-12-31 | $20.86 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | -28.01% | 🇺🇸 USA |
 Novartis NVS | $53.19 B | -61.23% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | $34.38 B | -74.94% | 🇺🇸 USA |
 Eli Lilly LLY | $53.14 B | -61.27% | 🇺🇸 USA |
 Amgen AMGN | $90.92 B | -33.74% | 🇺🇸 USA |
 Merck MRK | $69.04 B | -49.68% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $65.67 B | -52.14% | 🇺🇸 USA |
 AstraZeneca AZN | $61.95 B | -54.85% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $58.82 B | -57.13% | 🇬🇧 UK |